INS and type 2 diabetes mellitus: The Chinese T2DM treatment guidelines (2013 edition) recommends metformin or alpha-glycosidase inhibitor/insulin secretagogues as the first-line therapy and alpha-glycosidase inhibitor/insulin secretagogues, thiazolidinedione, and DPP 4 inhibitors as second-line therapy.